CGM for Management of Type 2 Diabetes in Pregnancy
Eligible age
18–50 yrs
Accepts
Women
Locations
7 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The goal of this clinical trial is to learn if continuous glucose monitoring works better than self-monitoring of blood glucose (fingersticks) to treat type 2 diabetes in pregnancy. It will also learn about all risk factors (biologic, personal, social) for maternal and infant complications in type 2 diabetes pregnancies. The main questions it aims to answer are: 1. Does continuous glucose monitoring improve infant outcomes compared to self-monitoring of blood glucose? 2. Does continuous glucose monitoring improve maternal diabetes control and other maternal outcomes compared to self-monitoring of blood glucose? 3. What other factors increase the risk of maternal and infant complications? Participants will: 1. Use continuous glucose monitoring or self-monitoring of blood glucose to monitor blood sugar control from enrollment until delivery 2. Have blood drawn at enrollment, 24 weeks, 34 weeks and delivery to measure hemoglobin A1c levels and store blood for future analysis 3. Complete surveys about social support, environmental stressors, diabetes distress and glucose monitoring satisfaction at research visits 4. Have umbilical cord blood collected at delivery for analysis
Sponsor: University of Alabama at Birmingham
You may qualify if…
- ✓ Type 2 diabetes mellitus treated with daily insulin injections or oral hypoglycemic agents diagnosed before pregnancy or at less than 14 weeks gestation with hemoglobin A1c 6.5% or greater
- ✓ Pregnant with viable fetus at 6 to less than 23 weeks gestation
- ✓ Maternal age 18-50 years old
You may not qualify if…
- ✕ Unable or unwilling to wear CGM due to intolerance to medical-grade adhesives or skin conditions
- ✕ Multiple gestation
- ✕ Major fetal anomaly or two or more minor fetal anomalies
- ✕ Planned delivery outside study consortium
- ✕ Participating in another conflicting interventional study
- ✕ Participation in this trial in a previous pregnancy
- ✕ Patient unable to consent
- ✕ Physician refusal for other reasons
Where it's recruiting
Birmingham
San Diego
Chapel Hill
Portland
Philadelphia
Greenville
Houston
Source: ClinicalTrials.gov · NCT06628453 · last updated 2025-06-15